The proposal for continuation of this Program Project Grant (PPG) is inspired by new opportunities to understand mechanisms of neurotransmitter transporters (NTs) in the physiological processes underlying neurotransmission in general, and their involvement in drug addiction and abuse in particular. The focus is on the transporter systems for dopamine (DAT), serotonin (SERT), and norepinephrine (NET), with generalizations and comparisons to other Na+Cl- dependent biogenic amine transporters. The broad aims are to achieve a mechanistic characterization, in a detailed structural context, of multifaceted NT function and modulation by substrates and ligands.
The aims address regulation and modulation of NT functional characteristics by interactions with their environment (e.g., by oligomerization, scaffold-binding, etc.) and by phosphorylation of the intracellular segments (N- and C-terminals, and loops). The studies aim to discover functional and structural properties of interactions 1) among specific NT structural elements, and 2) with other proteins such as PDZ domains and kinases, in key processes including cell surface expression and stabilization, and the regulation of substrate uptake and efflux. Such insights are essential to understand mechanisms responsible for pharmacological properties of abused substances and stimulants (e.g., cocaine, amphetamine and MDMA-ecstasy) and of major classes of therapeutic agents (e.g., antidepressants) that act directly on NTs. The synergistic construct of the PPG makes it possible to address the regulation of NT function with multidisciplinary approaches in collaborations and coordinated experiments using electrophysiological and pharmacological assays of NT activity, as well as biochemical procedures (such as cysteine cross-linking and accessibility scans) in wild type, mutant, phosphorylated and fused-protein expression constructs (in Projects 2-4 and Core B), biophysical measurements and computational evaluations of structure, affinity and selectivity in protein-protein interactions (in Projects 2 and 1), discovery (in Project 2) and interpretation of selectivity in high-throughput protein-interaction microarrays (in Projects 2 and 1), and shared contexts of structural models and data management systems provided by Project 1 and Core A.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
2P01DA012408-07
Application #
6857028
Study Section
Special Emphasis Panel (ZDA1-RXL-E (06))
Program Officer
Hillery, Paul
Project Start
1999-07-09
Project End
2010-03-31
Budget Start
2005-04-05
Budget End
2006-03-31
Support Year
7
Fiscal Year
2005
Total Cost
$1,046,772
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Physiology
Type
Schools of Medicine
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Mayer, Felix P; Schmid, Diethart; Owens, W Anthony et al. (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408-2417
Quick, Matthias; Abramyan, Ara M; Wiriyasermkul, Pattama et al. (2018) The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc Natl Acad Sci U S A 115:E7924-E7931
Herborg, Freja; Andreassen, Thorvald F; Berlin, Frida et al. (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250-7262
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2018) How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties. BMC Biol 16:31
Doktorova, Milka; Weinstein, Harel (2018) Accurate In Silico Modeling of Asymmetric Bilayers Based on Biophysical Principles. Biophys J 115:1638-1643
LeVine, Michael V; Cuendet, Michel A; Razavi, Asghar M et al. (2018) Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter. Biophys J 114:10-14
Wragg, Rachel T; Parisotto, Daniel A; Li, Zhenlong et al. (2017) Evolutionary Divergence of the C-terminal Domain of Complexin Accounts for Functional Disparities between Vertebrate and Invertebrate Complexins. Front Mol Neurosci 10:146
Doktorova, M; Harries, D; Khelashvili, G (2017) Determination of bending rigidity and tilt modulus of lipid membranes from real-space fluctuation analysis of molecular dynamics simulations. Phys Chem Chem Phys 19:16806-16818
Runegaard, Annika H; Jensen, Kathrine L; Fitzpatrick, CiarĂ¡n M et al. (2017) Preserved dopaminergic homeostasis and dopamine-related behaviour in hemizygous TH-Cre mice. Eur J Neurosci 45:121-128
Jensen, Kathrine L; Runegaard, Annika H; Weikop, Pia et al. (2017) Assessment of Dopaminergic Homeostasis in Mice by Use of High-performance Liquid Chromatography Analysis and Synaptosomal Dopamine Uptake. J Vis Exp :

Showing the most recent 10 out of 146 publications